Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Kidney Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 165 articles:
HTML format
Text format



Single Articles


    September 2019
  1. LAUTERIO A, De Carlis R, Di Sandro S, Buscemi V, et al
    Delayed kidney transplantation in combined liver-kidney transplantation for polycystic liver and kidney disease.
    Transpl Int. 2019 Sep 27. doi: 10.1111/tri.13537.
    PubMed     Text format     Abstract available


  2. VOCK DM, Matas AJ
    Rapid Discontinuation of Prednisone in Kidney Transplant Recipients from At-Risk Subgroups: An OPTN/SRTR Analysis.
    Transpl Int. 2019 Sep 26. doi: 10.1111/tri.13530.
    PubMed     Text format     Abstract available


  3. BENJAMENS S, van den Berg TAJ, Kuipers TGJ, Moers C, et al
    Kidney temperature during living donor kidney transplantation is associated with short-term measured glomerular filtration rate - a prospective study.
    Transpl Int. 2019 Sep 20. doi: 10.1111/tri.13528.
    PubMed     Text format     Abstract available


  4. RUMMO O, Carmellini M, Kamar N, Durrbach A, et al
    Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patients.
    Transpl Int. 2019 Sep 19. doi: 10.1111/tri.13527.
    PubMed     Text format     Abstract available


  5. HOLTTA T, Gordin D, Rahkonen O, Turanlahti M, et al
    Good Long-term renal graft survival and low incidence of cardiac pathology in adults after short dialysis period and renal transplantation in early childhood-a cohort study.
    Transpl Int. 2019 Sep 10. doi: 10.1111/tri.13521.
    PubMed     Text format     Abstract available


  6. CAMPI R, Vignolini G, Savi E, Sessa F, et al
    Robotic kidney transplantation allows safe access for transplant renal biopsy and percutaneous procedures.
    Transpl Int. 2019 Sep 4. doi: 10.1111/tri.13517.
    PubMed     Text format     Abstract available


  7. NAIK AS, Zhong Y, Parasuraman R, Doshi M, et al
    The temporal and long-term impact of donor body mass index on recipient outcomes after kidney transplantation - a retrospective study.
    Transpl Int. 2019 Sep 3. doi: 10.1111/tri.13505.
    PubMed     Text format     Abstract available


    August 2019
  8. GOLSHAYAN D, Pascual M
    Burden of end-stage renal disease and evolving challenges in kidney transplantation.
    Transpl Int. 2019 Aug 8. doi: 10.1111/tri.13490.
    PubMed     Text format     Abstract available


  9. LIM WH, Au E, Krishnan A, Wong G, et al
    Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?
    Transpl Int. 2019 Aug 6. doi: 10.1111/tri.13486.
    PubMed     Text format     Abstract available


  10. VIKLICKY O
    Systemic inflammation in kidney transplant candidates: a hidden threat?
    Transpl Int. 2019 Aug 2. doi: 10.1111/tri.13485.
    PubMed     Text format     Abstract available


    July 2019
  11. BUI K, Kilambi V, Mehrotra S
    Functional-Status-Based Risk-Benefit Analyses of High-KDPI Kidney Transplant vs. Dialysis.
    Transpl Int. 2019 Jul 19. doi: 10.1111/tri.13483.
    PubMed     Text format     Abstract available


  12. SPEER C, Kalble F, Nusshag C, Pego da Silva L, et al
    Outcomes and Complications Following ABO-incompatible Kidney Transplantation Performed after Desensitization by Semi-selective Immunoadsorption.
    Transpl Int. 2019 Jul 19. doi: 10.1111/tri.13482.
    PubMed     Text format     Abstract available


  13. BOS M
    Can disparity in access to living-donor kidney transplants between ethnic groups be mitigated?
    Transpl Int. 2019 Jul 18. doi: 10.1111/tri.13480.
    PubMed     Text format     Abstract available


  14. FERREIRA AN, Felipe CR, Cristelli M, Viana L, et al
    Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor.
    Transpl Int. 2019 Jul 6. doi: 10.1111/tri.13478.
    PubMed     Text format     Abstract available


  15. DURAND CM, Garonzik-Wang J, Desai NM
    Reclaiming missed opportunities: a strategy of targeted direct-acting antiviral prophylaxis for HCV-seronegative recipients of HCV-seropositive donor kidneys.
    Transpl Int. 2019;32:690-692.
    PubMed     Text format    


    June 2019
  16. MAINRA R, Wong G, Pilmore H, Lim WH, et al
    Association of prevalent vascular disease with allograft failure and mortality in live-donor kidney transplant recipients - a retrospective cohort study.
    Transpl Int. 2019 Jun 26. doi: 10.1111/tri.13473.
    PubMed     Text format     Abstract available


  17. MOGULLA M, Bhattacharjya S, Clayton PA
    Risk factors for and outcomes of delayed graft function in living donor kidney transplantation - a retrospective study.
    Transpl Int. 2019 Jun 17. doi: 10.1111/tri.13472.
    PubMed     Text format     Abstract available


  18. SEXTON DJ, O'Kelly P, Williams Y, Plant WD, et al
    Progressive improvement in short, medium and long-term graft survival in kidney transplantation patients in Ireland - a retrospective study.
    Transpl Int. 2019 Jun 17. doi: 10.1111/tri.13470.
    PubMed     Text format     Abstract available


    May 2019
  19. LAW J, Ali O, Dobrin A, Brar H, et al
    Significance of atypical urinary cytology in the evaluation of patients with end stage renal disease for kidney transplantation.
    Transpl Int. 2019 May 17. doi: 10.1111/tri.13464.
    PubMed     Text format     Abstract available


  20. DZIODZIO T, Jara M, Hardt J, Weiss S, et al
    Effects of expanded allocation programs and organ and recipient quality metrics on transplant-related costs in kidney transplantation - an institutional analysis.
    Transpl Int. 2019 May 17. doi: 10.1111/tri.13463.
    PubMed     Text format     Abstract available


    April 2019
  21. KHER A, Kher V
    Utility or futility of Interleukin 2 receptor antagonist (IL2RA) induction in kidney transplants- the devil is in the detail.
    Transpl Int. 2019 Apr 10. doi: 10.1111/tri.13440.
    PubMed     Text format     Abstract available


  22. MINNEE RC, Darwish Murad S, Polak WG, Metselaar HJ, et al
    Combined liver-kidney transplantation; two for the price of one?
    Transpl Int. 2019 Apr 8. doi: 10.1111/tri.13438.
    PubMed     Text format     Abstract available


    March 2019
  23. GOUMARD A, Sautenet B, Bailly E, Miquelestorena-Standley E, et al
    Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies - a retrospective study.
    Transpl Int. 2019 Mar 23. doi: 10.1111/tri.13428.
    PubMed     Text format     Abstract available


  24. CHATELET V, Gatault P, Hazzan M, Anglicheau D, et al
    Transplant center characteristics associated with living-donor kidney transplantation: A cohort study with a hierarchical modeling approach.
    Transpl Int. 2019 Mar 22. doi: 10.1111/tri.13429.
    PubMed     Text format     Abstract available


  25. LUND KP, von Stemann JH, Eriksson F, Hansen MB, et al
    IL-10-specific autoantibodies predict major adverse cardiovascular events in kidney transplanted patients - a retrospective cohort study.
    Transpl Int. 2019 Mar 18. doi: 10.1111/tri.13425.
    PubMed     Text format     Abstract available


  26. KNIGHT SR
    Routine adherence monitoring after renal transplantation.
    Transpl Int. 2019 Mar 1. doi: 10.1111/tri.13422.
    PubMed     Text format     Abstract available


  27. DELSANTE M, Maggiore U, Levi J, Kleiner DE, et al
    Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates.
    Transpl Int. 2019;32:300-312.
    PubMed     Text format     Abstract available


  28. CHEN JHC, Hughes P, Woodroffe C, Ferrari P, et al
    Pre- and postdonation kidney function in donors of a kidney paired donation with unique criteria for donor glomerular filtration rate - a longitudinal cohort analysis.
    Transpl Int. 2019;32:291-299.
    PubMed     Text format     Abstract available


  29. EGELAND EJ, Reisaeter AV, Robertsen I, Midtvedt K, et al
    High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study.
    Transpl Int. 2019;32:257-269.
    PubMed     Text format     Abstract available


    February 2019
  30. MUMFORD L, Maxwell H, Ahmad N, Marks SD, et al
    The impact of changing practice on improved outcomes of paediatric renal transplantation in the united kingdom: a twenty-five year review.
    Transpl Int. 2019 Feb 23. doi: 10.1111/tri.13418.
    PubMed     Text format     Abstract available


  31. TINTI F, Mitterhofer AP, Umbro I, Nightingale P, et al
    Combined Liver-Kidney Transplantation (CLKT) versus Liver Transplant alone (LTA) based on KDIGO stratification of estimated glomerular filtration rate (eGFR): Data from the United Kingdom Transplant Registry - a retrospective cohort study.
    Transpl Int. 2019 Feb 21. doi: 10.1111/tri.13413.
    PubMed     Text format     Abstract available


  32. GRUPPER A, Schwartz D, Baruch R, Schwartz IF, et al
    Kidney Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity.
    Transpl Int. 2019 Feb 21. doi: 10.1111/tri.13415.
    PubMed     Text format     Abstract available


  33. FRANCO A, Moreso F, Merino E, Sancho A, et al
    Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: A prospective study.
    Transpl Int. 2019 Feb 17. doi: 10.1111/tri.13410.
    PubMed     Text format     Abstract available


  34. GUSTAVSEN MT, Midtvedt K, Lonning K, Jacobsen T, et al
    Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation.
    Transpl Int. 2019 Feb 15. doi: 10.1111/tri.13412.
    PubMed     Text format     Abstract available


  35. DUBE GK, Brennan C, Husain SA, Crew RJ, et al
    Outcomes of kidney transplant from deceased donors with acute kidney injury and prolonged cold ischemia time.
    Transpl Int. 2019 Feb 3. doi: 10.1111/tri.13406.
    PubMed     Text format     Abstract available


  36. SMITH B, Cornell LD, Smith M, Cortese C, et al
    A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study.
    Transpl Int. 2019;32:173-183.
    PubMed     Text format     Abstract available


  37. GILLIS KA, Lees JS, Ralston MR, Glen JA, et al
    Interaction between socioeconomic deprivation and likelihood of pre-emptive transplantation: influence of competing risks and referral characteristics - a retrospective study.
    Transpl Int. 2019;32:153-162.
    PubMed     Text format     Abstract available


    January 2019
  38. SHAMALI A, Kassimatis T, Phillips BL, Burton H, et al
    Duration of delayed graft function and outcomes after kidney transplantation from controlled donation after circulatory death donors: a retrospective study.
    Transpl Int. 2019 Jan 26. doi: 10.1111/tri.13403.
    PubMed     Text format     Abstract available


  39. REUSZ GS
    Urinary proteomics: fancy gadgetry or a clinically useful diagnostic instrument? The end-user's perspective.
    Transpl Int. 2019;32:25-27.
    PubMed     Text format    


  40. KRAMER CSM, Israeli M, Mulder A, Doxiadis IIN, et al
    The long and winding road towards epitope matching in clinical transplantation.
    Transpl Int. 2019;32:16-24.
    PubMed     Text format     Abstract available


  41. HAMEED A, Dervish S, Rogers N, Pleass H, et al
    A novel, customized 3D-printed perfusion chamber for normothermic machine perfusion of the kidney.
    Transpl Int. 2019;32:107-109.
    PubMed     Text format    


  42. CIONI M, Nocera A, Tagliamacco A, Basso S, et al
    Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.
    Transpl Int. 2019;32:38-48.
    PubMed     Text format     Abstract available


    December 2018
  43. DEVRESSE A, Tinel C, Vermorel A, Snanoudj R, et al
    No clinical benefit of rapid vs gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.
    Transpl Int. 2018 Dec 19. doi: 10.1111/tri.13392.
    PubMed     Text format     Abstract available


  44. MANOOK M, Bradbury L, Barnett ANR, Osei-Bordom D, et al
    For the many: permitting deceased donor kidney transplantation across low-titre blood group antibodies can reduce wait times for blood group B recipients, and improve the overall number of 000MM transplants- a multicentre observational cohort study.
    Transpl Int. 2018 Dec 14. doi: 10.1111/tri.13389.
    PubMed     Text format     Abstract available


  45. SINGAL AK, Ong S, Satpathy S, Kamath PS, et al
    Simultaneous Liver Kidney Transplantation.
    Transpl Int. 2018 Dec 10. doi: 10.1111/tri.13388.
    PubMed     Text format     Abstract available


  46. VAN DEN BERG TAJ, Minnee RC, Lisman T, Nieuwenhuijs-Moeke GJ, et al
    Perioperative Antithrombotic Therapy Does Not Increase the Incidence of Early Postoperative Thromboembolic Complications and Bleeding in Kidney Transplantation. - a retrospective study.
    Transpl Int. 2018 Dec 10. doi: 10.1111/tri.13387.
    PubMed     Text format     Abstract available


  47. KROENCKE S
    The relevance of donor satisfaction after living kidney donation-a plea for a routine psychosocial follow-up.
    Transpl Int. 2018;31:1330-1331.
    PubMed     Text format    


    November 2018
  48. LIM WH, Coates PT, Russ GR, Russell C, et al
    Weekend effect on early allograft outcome after kidney transplantation- a multi-centre cohort study.
    Transpl Int. 2018 Nov 14. doi: 10.1111/tri.13377.
    PubMed     Text format     Abstract available


  49. PLADYS A, Morival C, Couchoud C, Jacquelinet C, et al
    Outcome-dependent geographic and individual variations in the access to renal transplantation in incident dialyzed patients: a French nationwide cohort study.
    Transpl Int. 2018 Nov 14. doi: 10.1111/tri.13376.
    PubMed     Text format     Abstract available


  50. PUIG-GAY N, Jacobs-Cacha C, Sellares J, Guirado L, et al
    Apolipoprotein A-Ib as a biomarker of FSGS recurrence after kidney transplantation: Diagnostic performance and assessment of its prognostic value - a multi-centre cohort study.
    Transpl Int. 2018 Nov 8. doi: 10.1111/tri.13372.
    PubMed     Text format     Abstract available


  51. KARAHAN GE, Claas FHJ, Heidt S
    Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies.
    Transpl Int. 2018;31:1189-1197.
    PubMed     Text format     Abstract available


    October 2018
  52. RATTANAVICH R, Malone AF, Alhamad T
    Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients.
    Transpl Int. 2018 Oct 29. doi: 10.1111/tri.13369.
    PubMed     Text format    


  53. KANZELMEYER NK, Zurbig P, Mischak H, Metzger J, et al
    Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation- a pilot study.
    Transpl Int. 2018 Oct 25. doi: 10.1111/tri.13363.
    PubMed     Text format     Abstract available


  54. MCCAUGHAN JA, Tinckam KJ
    Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
    Transpl Int. 2018;31:1059-1070.
    PubMed     Text format     Abstract available


  55. OZCAKAR ZB, Keven K, Cakar N, Yalcinkaya F, et al
    Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis.
    Transpl Int. 2018;31:1181-1184.
    PubMed     Text format    


  56. GAY S, Levrat A, Dorez D
    Controlled donation after circulatory death in France: first results of a nonuniversity pilot centre.
    Transpl Int. 2018;31:1178-1180.
    PubMed     Text format    


  57. NOVOTNY M, Hruba P, Vichova P, Maluskova J, et al
    Isolated v-lesion represents a benign phenotype of vascular rejection of the kidney allograft - a retrospective study.
    Transpl Int. 2018;31:1153-1163.
    PubMed     Text format     Abstract available


    September 2018
  58. YU JW, Gupta G, Kang L, Bandyopadhyay D, et al
    Obesity Does Not Significantly Impact Outcomes Following Simultaneous Liver Kidney Transplantation: Review of the UNOS Database - a retrospective study.
    Transpl Int. 2018 Sep 20. doi: 10.1111/tri.13352.
    PubMed     Text format     Abstract available


  59. SHEN J, Zhou Y, Chen Y, Li X, et al
    Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-centre pilot study.
    Transpl Int. 2018 Sep 10. doi: 10.1111/tri.13341.
    PubMed     Text format     Abstract available


  60. TABER DJ, Su Z, Fleming JN, Pilch NA, et al
    The Impact of Time-Varying Clinical Surrogates on Disparities in African-American Kidney Transplant Recipients - a retrospective longitudinal cohort study.
    Transpl Int. 2018 Sep 3. doi: 10.1111/tri.13338.
    PubMed     Text format     Abstract available


    August 2018
  61. MENJIVAR A, Torres X, Paredes D, Avinyo N, et al
    Assessment of donor satisfaction as an essential part of living donor kidney transplantation: an eleven-year retrospective study.
    Transpl Int. 2018 Aug 25. doi: 10.1111/tri.13334.
    PubMed     Text format     Abstract available


  62. DANTEC A, Selistre L, Lemoine S, Buron F, et al
    Performances of Creatinine-Based GFR Estimating Equations in Simultaneous Pancreas-Kidney Transplant Recipients: a single center cohort study.
    Transpl Int. 2018 Aug 17. doi: 10.1111/tri.13333.
    PubMed     Text format     Abstract available


  63. VAN DIJK M, van Roon AM, Said MY, Bemelman FJ, et al
    Long-Term Cardiovascular Outcome of Renal Transplant Recipients after Early Conversion to Everolimus Compared to Calcineurin Inhibition: Results from the Randomized Controlled MECANO Trial.
    Transpl Int. 2018 Aug 14. doi: 10.1111/tri.13322.
    PubMed     Text format     Abstract available


  64. SCHOPMEYER L, El Moumni M, Nieuwenhuijs-Moeke GJ, Berger SP, et al
    Frailty has a significant influence on postoperative complications after kidney transplantation.
    Transpl Int. 2018 Aug 12. doi: 10.1111/tri.13330.
    PubMed     Text format     Abstract available


  65. BURGHUBER CK, Kandioler D, Strobl S, Mittlbock M, et al
    Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.
    Transpl Int. 2018 Aug 12. doi: 10.1111/tri.13329.
    PubMed     Text format     Abstract available


  66. FERRARI P
    Early kidney allograft loss-Is there scope for improvement?
    Transpl Int. 2018;31:864-866.
    PubMed     Text format    


  67. MCKENNA GJ
    Medication trade-offs-Not all noncompliance is what it seems.
    Transpl Int. 2018;31:861-863.
    PubMed     Text format    


  68. SABLIK KA, Clahsen-van Groningen MC, Looman CWN, Damman J, et al
    Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study.
    Transpl Int. 2018;31:900-908.
    PubMed     Text format     Abstract available


    July 2018
  69. OBLAK M, Mlinsek G, Kandus A, Buturovic-Ponikvar J, et al
    Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial.
    Transpl Int. 2018 Jul 31. doi: 10.1111/tri.13323.
    PubMed     Text format     Abstract available


  70. CHERUKURI A, Mehta R, Sood P, Hariharan S, et al
    Early Allograft Inflammation and Scarring Associate with Graft Dysfunction and Poor Outcomes in Renal Transplant Recipients with Delayed Graft Function.
    Transpl Int. 2018 Jul 14. doi: 10.1111/tri.13318.
    PubMed     Text format     Abstract available


  71. DE SANDES-FREITAS TV, Pinheiro PMA, de Mattos Brito Oliveira Sales ML, Girao CM, et al
    The impact of everolimus in reducing cytomegalovirus events in kidney transplant recipients on steroid-avoidance strategy: 3-year follow-up of a randomized clinical.
    Transpl Int. 2018 Jul 3. doi: 10.1111/tri.13313.
    PubMed     Text format     Abstract available


  72. FEHR T
    Elderly kidney donors: better than their reputation-but where are the limits?
    Transpl Int. 2018;31:700-702.
    PubMed     Text format    


  73. SAMPAIO MS, Chopra B, Tang A, Sureshkumar KK, et al
    Impact of cold ischemia time on the outcomes of kidneys with Kidney Donor Profile Index >/=85%: mate kidney analysis - a retrospective study.
    Transpl Int. 2018;31:729-738.
    PubMed     Text format     Abstract available


    June 2018
  74. GIRAL M, Renaudin K, Naesens M, Luning R, et al
    The 1-year Renal Biopsy Index (1-RBI): a scoring system to drive biopsy indication at 1-year post-kidney transplantation.
    Transpl Int. 2018 Jun 12. doi: 10.1111/tri.13290.
    PubMed     Text format     Abstract available


  75. LA MANNA G, Capelli I
    Atrial changes after kidney transplant: what diagnostic and therapeutic perspectives?
    Transpl Int. 2018 Jun 1. doi: 10.1111/tri.13287.
    PubMed     Text format     Abstract available


  76. SANDAL S, Paraskevas S, Cantarovich M, Baran D, et al
    Renal resistance thresholds during hypothermic machine perfusion and transplantation outcomes - a retrospective cohort study.
    Transpl Int. 2018;31:658-669.
    PubMed     Text format     Abstract available


  77. SUSAL C, Slavcev A, Pham L, Zeier M, et al
    The possible critical role of T-cell help in DSA-mediated graft loss.
    Transpl Int. 2018;31:577-584.
    PubMed     Text format     Abstract available


    May 2018
  78. LEE D, Whitlam JB, Cook N, Walker AM, et al
    Lifetime Risk of End-stage Kidney Disease in Living Donors for Pediatric Kidney Transplant Recipients in Australia and New Zealand.
    Transpl Int. 2018 May 30. doi: 10.1111/tri.13284.
    PubMed     Text format     Abstract available


  79. MENDEL L, Albano L, Bentellis I, Yandza T, et al
    Safety of Dual Kidney Transplantation compared to Single Kidney Transplantation from expanded criteria donors: a single center cohort of 39 recipients.
    Transpl Int. 2018 May 17. doi: 10.1111/tri.13280.
    PubMed     Text format     Abstract available


  80. BENJAMENS S, Yakar D, Slart RHJA, Sanders JF, et al
    The fear for contrast-induced nephropathy in kidney transplant recipients: Time for a paradigm-shift?
    Transpl Int. 2018 May 15. doi: 10.1111/tri.13277.
    PubMed     Text format     Abstract available


  81. RIVARD CJ, Tanabe T, Lanaspa MA, Watanabe H, et al
    Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to baboon xeno renal transplantation- an experimental study.
    Transpl Int. 2018 May 2. doi: 10.1111/tri.13273.
    PubMed     Text format     Abstract available


  82. NAGAI S, Safwan M, Collins K, Schilke RE, et al
    Liver Alone or Simultaneous Liver-Kidney Transplant?: Pre-transplant Chronic Kidney Disease and Post-transplant Outcome-a retrospective study.
    Transpl Int. 2018 May 2. doi: 10.1111/tri.13275.
    PubMed     Text format     Abstract available


  83. ARBIOL-ROCA A, Padro-Miquel A, Vidal-Alabro A, Hueso M, et al
    ANRIL as a genetic marker for cardiovascular events in renal transplant patients-an observational follow-up cohort study.
    Transpl Int. 2018 May 2. doi: 10.1111/tri.13276.
    PubMed     Text format     Abstract available


  84. KNEZEVIC I, Zalar B
    Pretransplant depression in lung recipients - a lost battle?
    Transpl Int. 2018;31:481-483.
    PubMed     Text format    


  85. HELDAL TF, Ueland T, Jenssen T, Hartmann A, et al
    Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study.
    Transpl Int. 2018;31:510-519.
    PubMed     Text format     Abstract available


  86. VILLE S, Imbert-Marcille BM, Coste-Burel M, Garandeau C, et al
    Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.
    Transpl Int. 2018;31:484-494.
    PubMed     Text format     Abstract available


    April 2018
  87. NIEL O, Bastard P
    Artificial intelligence improves estimation of tacrolimus area-under-the-concentration over time curve in renal transplant recipients.
    Transpl Int. 2018 Apr 24. doi: 10.1111/tri.13271.
    PubMed     Text format     Abstract available


  88. GELPI R, Rodriguez-Villar C, Paredes D, Roque R, et al
    "Safety of Hepatitis C Virus (HCV) treated donors for kidney transplantation (KT) excluding occult HCV infection through kidney biopsies."
    Transpl Int. 2018 Apr 23. doi: 10.1111/tri.13270.
    PubMed     Text format     Abstract available


  89. OKADA D, Okumi M, Kakuta Y, Unagami K, et al
    Outcome of the Risk-stratified Desensitization Protocol in Donor-specific Antibody-positive Living Kidney Transplant Recipients: A Retrospective Study.
    Transpl Int. 2018 Apr 20. doi: 10.1111/tri.13269.
    PubMed     Text format     Abstract available


  90. ARSHAD A, Hodson J, Chappelow I, Inston NG, et al
    The impact of donor body mass index on outcomes after deceased kidney transplantation.
    Transpl Int. 2018 Apr 17. doi: 10.1111/tri.13263.
    PubMed     Text format     Abstract available


  91. CHATELET V, Bayat-Makoei S, Vigneau C, Launoy G, et al
    Renal transplantation outcome and social deprivation in the French Health Care system: a cohort study using the European Deprivation Index.
    Transpl Int. 2018 Apr 2. doi: 10.1111/tri.13161.
    PubMed     Text format     Abstract available


  92. CLEPER R
    Post-transplantation lymphoproliferative disease in pediatric kidney transplant recipients-early success does not mean the battle is over!
    Transpl Int. 2018;31:361-363.
    PubMed     Text format    


  93. KANZELMEYER NK, Maecker-Kolhoff B, Zierhut H, Lerch C, et al
    Graft outcomes following diagnosis of post-transplant lymphoproliferative disease in pediatric kidney recipients: a retrospective study.
    Transpl Int. 2018;31:367-376.
    PubMed     Text format     Abstract available


    March 2018
  94. MONTERO N, Redondo-Pachon D, Perez-Saez MJ, Crespo M, et al
    Dual kidney transplantation as a strategy to use expanded criteria donors: A systematic review.
    Transpl Int. 2018 Mar 27. doi: 10.1111/tri.13157.
    PubMed     Text format     Abstract available


  95. REGELE F, Kainz A, Kammer M, Beer A, et al
    Regression of left atrial diameter after kidney transplantation is associated with prolonged survival: an observational study.
    Transpl Int. 2018 Mar 25. doi: 10.1111/tri.13152.
    PubMed     Text format     Abstract available


  96. SCHMITT FCF, Salgado E, Friebe J, Schmoch T, et al
    Cell cycle arrest and cell death correlate with the extent of ischemia and reperfusion injury in patients following kidney transplantation - Results of an observational pilot study.
    Transpl Int. 2018 Mar 5. doi: 10.1111/tri.13148.
    PubMed     Text format     Abstract available


  97. PRONK MC, Slaats D, Zuidema WC, Hilhorst MT, et al
    "What if this is my chance to save my life?" A semistructured interview study on the motives and experiences of end-stage renal disease patients who engaged in public solicitation of a living kidney donor.
    Transpl Int. 2018;31:318-331.
    PubMed     Text format     Abstract available


  98. KUIPER GJAJM, Christiaans MHL, Mullens MHJM, Ten Cate H, et al
    Routine haemostasis testing before transplanted kidney biopsy: a cohort study.
    Transpl Int. 2018;31:302-312.
    PubMed     Text format     Abstract available


    February 2018
  99. ZAKY Z, Augustine JJ
    Hepatitis C Treatment in Kidney Transplant Recipients: The Need for Sustained Vigilance after Sustained Viral Response.
    Transpl Int. 2018 Feb 26. doi: 10.1111/tri.13143.
    PubMed     Text format     Abstract available


  100. HELDAL K, Midtvedt K, Hartmann A, Reisaeter AV, et al
    Estimated GFR in stable older kidney transplant recipients - are present algorithms valid? A national cross-sectional cohort study.
    Transpl Int. 2018 Feb 17. doi: 10.1111/tri.13137.
    PubMed     Text format     Abstract available


  101. JORGENSEN MB, Hornum M, van Hall G, Bistrup C, et al
    Reply to: Correspondence regarding the impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2018 Feb 12. doi: 10.1111/tri.13134.
    PubMed     Text format     Abstract available


  102. MOLNAR MZ, Eason JD, Gaipov A, Talwar M, et al
    History of Psychosis and Mania, and Outcomes After Kidney Transplantation.
    Transpl Int. 2018 Feb 6. doi: 10.1111/tri.13127.
    PubMed     Text format     Abstract available


  103. BUNTHOF KLW, Verhoeks CM, van den Brand JAJG, Hilbrands LB, et al
    Graft intolerance syndrome requiring graft nephrectomy after late kidney graft failure: can it be predicted? A retrospective cohort study.
    Transpl Int. 2018;31:220-229.
    PubMed     Text format     Abstract available


  104. GLEISS A, Oberbauer R, Heinze G
    An unjustified benefit: immortal time bias in the analysis of time-dependent events.
    Transpl Int. 2018;31:125-130.
    PubMed     Text format     Abstract available


    January 2018
  105. PIPPIAS M, Stel VS, Kramer A, Abad Diez JM, et al
    Access to kidney transplantation in European adults aged 75 to 84 years and related outcomes: An analysis of the ERA-EDTA Registry database.
    Transpl Int. 2018 Jan 30. doi: 10.1111/tri.13125.
    PubMed     Text format     Abstract available


  106. BERGFELD L, Werzowa J, Saemann M, Hecking M, et al
    The impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2018 Jan 29. doi: 10.1111/tri.13124.
    PubMed     Text format     Abstract available


  107. FERNANDEZ-RUIZ M, Polanco N, Garcia-Santiago A, Munoz R, et al
    Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up.
    Transpl Int. 2018 Jan 22. doi: 10.1111/tri.13118.
    PubMed     Text format     Abstract available


  108. HELANTERA I, Raiha J, Finne P, Lempinen M, et al
    Early failure of kidney transplants in the current era - a national cohort study.
    Transpl Int. 2018 Jan 16. doi: 10.1111/tri.13115.
    PubMed     Text format     Abstract available


  109. REUSZ GS, Molnar MZ
    Are kidney transplantation outcomes improved in children weighting 15 kilograms or less in the last decades?
    Transpl Int. 2018 Jan 16. doi: 10.1111/tri.13113.
    PubMed     Text format     Abstract available


  110. MULLER YD, Nseir G, Rotman S, Vionnet J, et al
    Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
    Transpl Int. 2018 Jan 12. doi: 10.1111/tri.13111.
    PubMed     Text format     Abstract available


  111. LEE D, Whitlam JB, Cook N, Manzoor M, et al
    Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challenge.
    Transpl Int. 2018;31:118-120.
    PubMed     Text format    


  112. DESY O, Beland S, Vallin P, Riopel J, et al
    IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study.
    Transpl Int. 2018;31:92-101.
    PubMed     Text format     Abstract available


  113. PARAJULI S, Arpali E, Astor BC, Djamali A, et al
    Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection - a retrospective study.
    Transpl Int. 2018;31:32-37.
    PubMed     Text format     Abstract available


    December 2017
  114. BANAS B, Steubl D, Renders L, Chittka D, et al
    Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
    Transpl Int. 2017 Dec 28. doi: 10.1111/tri.13110.
    PubMed     Text format     Abstract available


  115. CHIODINI B, Herman J, Lolin K, Adams B, et al
    Outcomes of Kidney Transplantations in Children Weighing 15 Kilograms or less: a retrospective cohort study.
    Transpl Int. 2017 Dec 27. doi: 10.1111/tri.13108.
    PubMed     Text format     Abstract available


  116. AYAZ-SHAH AA, Hussain S, Knight SR
    Do Clinical Trials Reflect Reality? A Systematic Review of Inclusion/Exclusion Criteria in Trials of Renal Transplant Immunosuppression.
    Transpl Int. 2017 Dec 23. doi: 10.1111/tri.13109.
    PubMed     Text format     Abstract available


  117. PELLETIER RP, Balazs I, Adams P, Rajab A, et al
    Clinical utility of C3d binding donor specific anti-HLA antibody detection by single antigen beads after kidney transplantation - a retrospective study.
    Transpl Int. 2017 Dec 19. doi: 10.1111/tri.13106.
    PubMed     Text format     Abstract available


  118. PIPPIAS M, Jager KJ, Caskey F, Casula A, et al
    Kidney transplant outcomes from older deceased donors: A paired kidney analysis by the ERA-EDTA Registry.
    Transpl Int. 2017 Dec 5. doi: 10.1111/tri.13103.
    PubMed     Text format     Abstract available


  119. GIRERD S, Girerd N, Duarte K, Legendre C, et al
    Preemptive second kidney transplantation is associated with better graft survival compared to non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.
    Transpl Int. 2017 Dec 5. doi: 10.1111/tri.13105.
    PubMed     Text format     Abstract available


  120. FEHR T, Immer F
    Marginal organ allocation: old and new REALity.
    Transpl Int. 2017;30:1212-1214.
    PubMed     Text format    


    November 2017
  121. SERPER M, Reese P, Patzer R, Levitsky J, et al
    The Prevalence, Risk Factors, and Outcomes of Medication Tradeoffs in Kidney and Liver Transplant Recipients: A Pilot Study.
    Transpl Int. 2017 Nov 25. doi: 10.1111/tri.13098.
    PubMed     Text format     Abstract available


    October 2017
  122. DORR CR, Oetting WS, Jacobson PA, Israni AK, et al
    Genetics of Acute Rejection after Kidney Transplantation.
    Transpl Int. 2017 Oct 14. doi: 10.1111/tri.13084.
    PubMed     Text format     Abstract available


  123. MOLNAR MZ
    Is kidney transplantation safe after careful selection of the recipients with a history of psychotic disorder?
    Transpl Int. 2017 Oct 11. doi: 10.1111/tri.13082.
    PubMed     Text format     Abstract available


  124. DHARNIDHARKA VR, Naik AS, Axelrod DA, Schnitzler MA, et al
    Center practice drives variation in choice of U.S. kidney transplant induction therapy: A retrospective analysis of contemporary practice.
    Transpl Int. 2017 Oct 7. doi: 10.1111/tri.13079.
    PubMed     Text format     Abstract available


    September 2017
  125. KOFMAN T, Pourcine F, Canoui-Poitrine F, Kamar N, et al
    Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.
    Transpl Int. 2017 Sep 25. doi: 10.1111/tri.13078.
    PubMed     Text format     Abstract available


  126. FERNANDEZ-RUIZ M, Origuen J, Lora D, Lopez-Medrano F, et al
    Herpes zoster in kidney transplant recipients: protective effect of anti-CMV prophylaxis and NK cells count. A single-center cohort study.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13076.
    PubMed     Text format     Abstract available


  127. LIM WH, Wong G
    The "Cold" Hard Facts - Seasonal Variation in Outcomes After Kidney Transplantation.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13077.
    PubMed     Text format     Abstract available


  128. LEEAPHORN N, Garg N, Khankin EV, Cardarelli F, et al
    Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Transpl Int. 2017 Sep 19. doi: 10.1111/tri.13075.
    PubMed     Text format     Abstract available


  129. STAPLETON CP, Conlon PJ, Phelan PJ
    Using omics to explore complications of kidney transplantation.
    Transpl Int. 2017 Sep 11. doi: 10.1111/tri.13067.
    PubMed     Text format     Abstract available


  130. ASTOR BC, Melamed ML, Mandelbrot DA, Djamali A, et al
    Seasonality of Mortality and Graft Failure among Kidney Transplant Recipients in the US.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13047.
    PubMed     Text format     Abstract available


  131. FILLER G, Ferris M
    We have to do more for former paediatric renal transplant recipients!
    Transpl Int. 2017 Sep 2. doi: 10.1111/tri.13058.
    PubMed     Text format     Abstract available


  132. GRIMBERT P
    Toward a better risk stratification for late antibody-mediated rejection in ABO incompatible kidney recipients.
    Transpl Int. 2017;30:863-864.
    PubMed     Text format    


    August 2017
  133. ENDEN K, Tainio J, Jalanko H, Jahnukainen K, et al
    Lower quality of life in young men after pediatric kidney transplantation when compared to healthy controls and survivors of childhood leukemia - a cross-sectional study.
    Transpl Int. 2017 Aug 29. doi: 10.1111/tri.13040.
    PubMed     Text format     Abstract available


  134. LAUTERIO A, De Carlis R, Di Sandro S, Ferla F, et al
    Bovine pericardium for multiple artery reconstruction in kidney transplantation.
    Transpl Int. 2017 Aug 23. doi: 10.1111/tri.13039.
    PubMed     Text format     Abstract available


  135. KHALID U, Ilham MA, Awad M, Elker D, et al
    Correspondence to: 'Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study'.
    Transpl Int. 2017 Aug 10. doi: 10.1111/tri.13019.
    PubMed     Text format     Abstract available


  136. LUQUE S, Lucia M, Bestard O
    Refinement of Humoral Immune-monitoring in Kidney Transplantation: the role of "hidden" Alloreactive Memory B cells.
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13014.
    PubMed     Text format     Abstract available


  137. ASSALINO M, Hadaya K, Andres A, Berney T, et al
    Discordant rejection in simultaneous pancreas and kidney transplantation: true discordance or analysis artefact ?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13017.
    PubMed     Text format     Abstract available


  138. GAYNOR JJ, Ciancio G
    Clinical depression as an unfavorable prognostic factor following kidney transplantation - How can we explain it?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13012.
    PubMed     Text format     Abstract available


  139. LENTINE KL, Naik AS, Ouseph R, Zhang Z, et al
    Antidepressant medication use before and after kidney transplant: implications for outcomes - A retrospective study.
    Transpl Int. 2017 Aug 3. doi: 10.1111/tri.13006.
    PubMed     Text format     Abstract available


    July 2017
  140. DELTOMBE C, Gillaizeau F, Anglicheau D, Morelon E, et al
    Is Pre-transplant sensitization against Angiotensin II Type1 Receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti HLA Luminex era?
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13009.
    PubMed     Text format     Abstract available


  141. TORRES IB, Reisaeter AV, Moreso F, Asberg A, et al
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.
    Transpl Int. 2017 Jul 1. doi: 10.1111/tri.13002.
    PubMed     Text format     Abstract available


    June 2017
  142. BOBAN MD, Tiefenthaler M
    Tangential Extraperitoneal Retrorenal (TER) approach: a specified uniform technique for renal transplant biopsy.
    Transpl Int. 2017 Jun 7. doi: 10.1111/tri.12994.
    PubMed     Text format     Abstract available


  143. MORATH C, Zeier M, Susal C
    Increased risk of infection-associated death with incompatible kidney transplantations.
    Transpl Int. 2017 Jun 6. doi: 10.1111/tri.12995.
    PubMed     Text format     Abstract available


  144. WAHBA R, Suwelack B, Arns W, Cakiroglu F, et al
    Rescue Allocation and Recipient Oriented Extended Allocation in kidney transplantation - Influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially non-accepted organs.
    Transpl Int. 2017 Jun 2. doi: 10.1111/tri.12993.
    PubMed     Text format     Abstract available


    May 2017
  145. CREMASCHI L, von Versen R, Benzing T, Wiesener M, et al
    Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: A health economic analysis from a German perspective.
    Transpl Int. 2017 May 27. doi: 10.1111/tri.12991.
    PubMed     Text format     Abstract available


  146. NORMAND G, Brunner F, Badet L, Buron F, et al
    Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national french survey study.
    Transpl Int. 2017 May 13. doi: 10.1111/tri.12983.
    PubMed     Text format     Abstract available


  147. KO EJ, Yu JH, Yang CW, Chung BH, et al
    Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: A nationwide cohort study.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12979.
    PubMed     Text format     Abstract available


  148. WILLICOMBE M, Goodall D, McLean AG, Taube D, et al
    Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12978.
    PubMed     Text format     Abstract available


  149. UPALA S, Sanguankeo A, Panichsillapakit T, Wijarnpreecha K, et al
    Reply to: an evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:535.
    PubMed     Text format    


  150. RINALDI S, Horne J, Madill J
    An evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:533-534.
    PubMed     Text format    


    April 2017
  151. GRIMBERT P, Thaunat O
    mTOR inhibitors and risk for chronic antibody-mediated rejection after kidney transplantation: Where are we now?
    Transpl Int. 2017 Apr 26. doi: 10.1111/tri.12975.
    PubMed     Text format     Abstract available


  152. PIHLSTROM HK, Gatti F, Hammarstrom C, Eide IA, et al
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.
    Transpl Int. 2017 Apr 24. doi: 10.1111/tri.12973.
    PubMed     Text format     Abstract available


  153. MCCAUGHAN JA, Courtney AE
    Successful kidney transplantation in highly sensitised, ultra-long term dialysis patients.
    Transpl Int. 2017 Apr 18. doi: 10.1111/tri.12970.
    PubMed     Text format     Abstract available


  154. LONZE BE, Bae S, Kraus ES, Holechek MJ, et al
    Outcomes and Risk Stratification for Late Antibody Mediated Rejection in Recipients of ABO-incompatible Kidney Transplants.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12969.
    PubMed     Text format     Abstract available


  155. VANHOVE T, Kinashi H, Nguyen TQ, Metalidis C, et al
    Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis.
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12960.
    PubMed     Text format     Abstract available


  156. FERRARI-LACRAZ S
    Donor-specific antibodies' C1q binding: improvement in kidney graft management?
    Transpl Int. 2017;30:344-346.
    PubMed     Text format    


  157. GO H, Shin S, Kim YH, Han DJ, et al
    Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
    Transpl Int. 2017;30:398-409.
    PubMed     Text format     Abstract available


  158. AMIN I, Butler AJ, Defries G, Russell NK, et al
    A single-centre experience of Roux-en-Y enteric drainage for pancreas transplantation.
    Transpl Int. 2017;30:410-419.
    PubMed     Text format     Abstract available


    March 2017
  159. FISHMAN JA, Ikle DN, Wilkinson RA
    Discrepant Serological Assays for Pneumococcus in Renal Transplant Recipients.
    Transpl Int. 2017 Mar 27. doi: 10.1111/tri.12959.
    PubMed     Text format     Abstract available


  160. BARLOW AD, Saeb-Parsy K, Watson CJ
    An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.
    Transpl Int. 2017 Mar 20. doi: 10.1111/tri.12957.
    PubMed     Text format     Abstract available


  161. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available


  162. MOKTEFI A, Parisot J, Desvaux D, Canoui-Poitrine F, et al
    C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Transpl Int. 2017;30:277-287.
    PubMed     Text format     Abstract available


    January 2017
  163. PALIN NK, Savikko J, Pasternack A, Rintala JM, et al
    Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study.
    Transpl Int. 2017;30:96-107.
    PubMed     Text format     Abstract available


  164. FINK S, Tsai MH, Schnitzler P, Zeier M, et al
    The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.
    Transpl Int. 2017;30:57-67.
    PubMed     Text format     Abstract available


  165. CAILLARD S, Becmeur C, Gautier-Vargas G, Olagne J, et al
    Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Transpl Int. 2017;30:29-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: